Day One Biopharmaceutical... (DAWN)
NASDAQ: DAWN
· Real-Time Price · USD
6.78
-0.03 (-0.44%)
At close: Aug 19, 2025, 11:44 AM
-0.44% (1D)
| Bid | 5.08 |
| Market Cap | 694.49M |
| Revenue (ttm) | 187.64M |
| Net Income (ttm) | -95M |
| EPS (ttm) | -0.89 |
| PE Ratio (ttm) | -7.62 |
| Forward PE | -7.83 |
| Analyst | Buy |
| Ask | 7.22 |
| Volume | 623,890 |
| Avg. Volume (20D) | 1,573,366 |
| Open | 6.98 |
| Previous Close | 6.81 |
| Day's Range | 6.78 - 7.12 |
| 52-Week Range | 5.63 - 16.76 |
| Beta | -1.27 |
About DAWN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DAWN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DAWN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Day One Biopharmaceuticals Inc. is scheduled to release its earnings on
Oct 29, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-15.7%
Day One Biopharmaceuticals shares are trading lowe...
Unlock content with
Pro Subscription
1 week ago
+2.08%
Day One Biopharmaceuticals shares are trading lower after the company reported worse-than-expected Q2 revenue results.
